カテゴリ： MarketLine, 企業調査, 台湾

Standard Chem & Pharm Co Ltd：企業の戦略・SWOT・財務分析

◆英語タイトル：Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4150
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：19
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：台湾
◆産業分野：Ingredients
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Standard Chem & Pharm Co Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Standard Chem & Pharm Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Standard Chem & Pharm Co Ltd (SCP) manufactures and markets pharmaceutical and healthcare products. The company’s product offerings include pharmaceuticals, supplements, and API. SCP’s drug delivery platforms include osmotic-controlled release oral system, pulsatile controlled release delivery, micro-encapsulation and lyophilization. SCP develops new products through its R&D facility, Standard Pharmaceutical Research Institute. The company provides out-licensing and in-licensing services, apart from services and partnership opportunities to government agencies, research institutes, and biotechnology firms to commercialize the niche products in the global market. The company has business presence in Taiwan, China, Vietnam, Thailand, South Korea, Malaysia, the Philippines, and the US. SCP is headquartered in Tainan, Sinying District, Taiwan.

Scope

- Detailed information on Standard Chem & Pharm Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Standard Chem & Pharm Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Standard Chem & Pharm Co Ltd including a breakdown and examination of key business segments
- Intelligence on Standard Chem & Pharm Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Standard Chem & Pharm Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Standard Chem & Pharm Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Standard Chem & Pharm Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Standard Chem & Pharm Co Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Standard Chem & Pharm Co Ltd: Company Overview
Standard Chem & Pharm Co Ltd: Overview and Key Facts
Standard Chem & Pharm Co Ltd: Overview
Standard Chem & Pharm Co Ltd: Key Facts
Standard Chem & Pharm Co Ltd: Key Employees
Standard Chem & Pharm Co Ltd: Major Products and Services
Standard Chem & Pharm Co Ltd: Company History
Standard Chem & Pharm Co Ltd: Locations and Subsidiaries
Standard Chem & Pharm Co Ltd: Key Competitors
Standard Chem & Pharm Co Ltd: Company Analysis
Standard Chem & Pharm Co Ltd: Business Description
Standard Chem & Pharm Co Ltd: SWOT Analysis
Standard Chem & Pharm Co Ltd: SWOT Overview
Standard Chem & Pharm Co Ltd: Strengths
Standard Chem & Pharm Co Ltd: Weaknesses
Standard Chem & Pharm Co Ltd: Opportunities
Standard Chem & Pharm Co Ltd: Threats
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Standard Chem & Pharm Co Ltd: Key Facts
Table 2: Standard Chem & Pharm Co Ltd: Key Employees
Table 3: Standard Chem & Pharm Co Ltd: Company History
Table 4: Standard Chem & Pharm Co Ltd: Locations and Subsidiaries
Table 5: Standard Chem & Pharm Co Ltd: Key Competitors

★海外企業調査レポート[Standard Chem & Pharm Co Ltd：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Geron Corp (GERN)-製薬・医療分野：企業M&A・提携分析
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …
  • Stada Arzneimittel AG (SAZ)：製薬・医療：M&Aディール及び事業提携情報
    Summary Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers a portfolio of product …
  • Monster Worldwide Inc：企業の戦略的SWOT分析
    Monster Worldwide Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • United Energy Group Ltd (467)：企業の財務・戦略的SWOT分析
    Summary United Energy Group Ltd (UEG) is an independent upstream oil and gas company that offers exploration and production of oil and gas reserves. The company's activities include merger and acquisition of oil and natural gas assets, exploitation, development and production of crude oil and natura …
  • Space Hellas S.A. (SPACE)：企業の財務・戦略的SWOT分析
    Space Hellas S.A. (SPACE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Yihai International Holding Ltd (1579)：企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Robert Half International Inc.：企業の戦略・SWOT・財務情報
    Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report Summary Robert Half International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • JetBlue Airways Corp：戦略・SWOT・企業財務分析
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Takeda Pharmaceuticals USA Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • Iberdrola, S.A.：企業のM&A・事業提携・投資動向
    Iberdrola, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iberdrola, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Drexel University：製薬・医療：M&Aディール及び事業提携情報
    Summary Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It …
  • Kazakhtelecom (KZTK)：企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vector Group Ltd (VGR)：企業の財務・戦略的SWOT分析
    Vector Group Ltd (VGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Dr. Reddy’s Laboratories Ltd (DRREDDY)：製薬・医療：M&Aディール及び事業提携情報
    Summary Dr. Reddy's Laboratories Ltd (Dr. Reddy's) is a pharmaceutical company which manufactures and markets generic formulations, active pharmaceutical ingredients, biosimilars and proprietary products. The company’s generic products are used for the treatment of conditions such as gastrointestina …
  • Bioasis Technologies Inc (BTI)：製薬・医療：M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • VBI Vaccines Inc (VBV)：製薬・医療：M&Aディール及び事業提携情報
    Summary VBI Vaccines Inc (VBI), a subsidiary of SciVac Therapeutics Inc is a biopharmaceutical company that discovers and develops novel vaccines for the treatment of immuno-oncology and infectious diseases. The company’s pipeline vaccine candidates include cytomegalovirus; glioblastoma multiforme a …
  • ReShape Lifesciences Inc (RSLS)：医療機器：M&Aディール及び事業提携情報
    Summary ReShape Lifesciences Inc (ReShape), formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic dise …
  • ADAMA Agricultural Solutions Ltd.：企業の戦略的SWOT分析
    ADAMA Agricultural Solutions Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Gridsum Holding, Inc. (GSUM)：企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Roche Diagnostics International Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆